Alogliptin Benzoate/Metformin Hydrochloride

苯甲酸阿格列汀/盐酸二甲双胍

Report date: 2022/12/29 13:46:55

Base Information

Drug NameAlogliptin Benzoate/Metformin Hydrochloride
Drug Alias NameAlogliptin Benzoate and Metformin Hydrochloride盐酸二甲双胍/苯甲酸阿格列汀SYR-322/metformin hydrochlorideMetformin Hydrochloride/Alogliptin Benzoatealogliptin benzoate + metformin hydrochloride (Takeda) +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2013/01/25
Country/TerritoryUnited StatesTaiwanSouth Korea +[7] 
CombinationsYes Metformin HydrochlorideAlogliptin Benzoate
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceuticals USA IncTeijin Pharma LtdTakeda Pharmaceutical Co Ltd +[6] 
Inactive CompaniesTakeda Pharmaceutical (China) Company Limited
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD13
Related LinksKEGG